Previous 10 | Next 10 |
We’re in the final stretch of June 2022 and the last few days of the second quarter. Gross Domestic Product results for the quarter and additional CPI data are also due out before July. Whether they reveal a recession, higher inflation, or something completely different may not matte...
Clinical-stage biotech Alaunos Therapeutics (NASDAQ:TCRT) announced on Monday that the company and the National Cancer Institute (NCI), agreed to extend their partnership for personalized TCR-T cell therapies to 2025. Per the terms of the Cooperative Research and Development Agreement (CRADA)...
HOUSTON, June 27, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced that the Company has extended its Cooperative Research and Development Agree...
There’s only one week left until we turn the page on June and the second quarter. With GDP numbers and more CPI data expected to show the progress in curbing inflation, the market’s risk appetite seems to change daily. But one of the more static trends in the stock market toda...
3 Penny Stocks to Watch in Mid-June 2022 Finding the best penny stocks to buy can be challenging. However, with the right tools and understanding of the stock market, making money with penny stocks can be much easier than previously imagined. For some context, penny stocks are stock...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Marygold Companies (NYSEAMERICAN: MGLD ) stock tops our gainers this morning. Bit Origin (NASDAQ: BTOG ) stock leads our pre-market losers. Earnings reports have shares on the move today. Source: onein...
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced that Kevin S. Boyle Sr., Chief Executive Officer and Drew Deniger, Ph.D., Vic...
HOUSTON, May 26, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced a Trials in Progress poster presentation at the 2022 American Society of Clini...
Alaunos Therapeutics, Inc. (TCRT) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Alex Lobo - Stern, Investor Relations Kevin Boyle - Chief Executive Officer Drew Deniger - Vice President, Research and Development Mike Wong - Vice President, Finance Conference Ca...
Alaunos Therapeutics press release (NASDAQ:TCRT): Q1 GAAP EPS of -$0.05 beats by $0.02. As of March 31, 2022, Alaunos had approximately $68.3 million in cash and cash equivalents. The Company anticipates its cash runway will be sufficient to fund operations into the second quarter of 20...
News, Short Squeeze, Breakout and More Instantly...
Alaunos Therapeutics Inc. Company Name:
TCRT Stock Symbol:
NASDAQ Market:
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...